Pharmaceuticals & Biotechnology

GlaxoSmithKline Pharmaceuticals Limited

ISIN: INE159A01016 · Data as of Jun 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
115
vs Last Month
+5 funds
Total Value
₹1,998.20 Cr
Avg Weight
0.72%
New Entries
10
Exits
14
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Mid Cap Rank #221
₹22.05 K Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
₹40.59 K Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
+84.1%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month GlaxoSmithKline Pharmaceuticals Limited is currently held by 115 active mutual funds with total exposure of ₹1,998.20 Cr. This month 10 funds entered and 14 funds exited. Tata India Pharma & Healthcare Fund-Direct Plan-Growth has the highest allocation at 4.12%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 4 Months?

Month Funds AMCs Status
Jun 2026 REFERENCE 115 48 / 49 ⏳ Partial — 48 of 49 AMCs uploaded
May 2026 110 49 / 49 ✅ Complete
Apr 2026 103 49 / 49 ✅ Complete
Mar 2026 95 48 / 49 ⏳ Partial — 48 of 49 AMCs uploaded

📌 Portfolio changes below are based on Jun 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Jun 2026?

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Index/ETF 67 0.38%
Equity 19 1.34%
Mid Cap 11 0.96%
Flexi Cap 3 1.01%
ELSS 3 1.11%
Small Cap 3 0.62%
Dividend Yield 2 1.91%
Multi Cap 2 1.32%
Multi Asset 2 0.85%
Aggressive Hybrid 1 2.04%
Balanced Advantage 1 1.83%
Value/Contra 1 0.8%
All Holdings

Which 115 Active Funds Hold GlaxoSmithKline Pharmaceuticals Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Tata Mutual Fund
Equity 4.12% ₹60.00 Cr +0.86%
Baroda BNP Paribas Dividend Yield Fund
Baroda BNP Paribas Mutual Fund
Dividend Yield 2.52% ₹15.44 Cr NEW
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 2.47% ₹223.77 Cr +0.13%
Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan Mutual Fund
Equity 2.28% ₹7.35 Cr +0.5%
DSP Nifty Midcap 150 Quality 50 ETF
DSP Mutual Fund
Index/ETF 2.15% ₹2.13 Cr +0.29%
DSP Nifty Midcap 150 Quality 50 Index Fund - Direct - Growth
DSP Mutual Fund
Index/ETF 2.15% ₹9.32 Cr +0.29%
UTI Nifty Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option
UTI Mutual Fund
Index/ETF 2.15% ₹5.26 Cr +0.29%
quant Healthcare Fund - Growth Option - Direct Plan
Quant Mutual Fund
Equity 2.04% ₹7.96 Cr +0.11%
Tata Aggressive Hybrid Fund -Direct Plan- Growth Option
Tata Mutual Fund
Aggressive Hybrid 2.04% ₹77.18 Cr NEW
ICICI Prudential Quant Fund Direct Plan Growth
ICICI Prudential Mutual Fund
Equity 1.96% ₹2.95 Cr +0.66%
DSP Quant Fund - Direct Plan - Growth
DSP Mutual Fund
Equity 1.92% ₹14.70 Cr NEW
THE WEALTH COMPANY FLEXI CAP FUND
The Wealth Company Mutual Fund
Flexi Cap 1.85% ₹4.44 Cr NEW
Bajaj Finserv Balanced Advantage Fund-Direct Plan-Growth
Bajaj Finserv Mutual Fund
Balanced Advantage 1.83% ₹22.70 Cr +0.83%
The Wealth Company Large & Mid Cap Fund
The Wealth Company Mutual Fund
Mid Cap 1.83% ₹1.72 Cr NEW
BAJAJ FINSERV MULTI CAP FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
Multi Cap 1.66% ₹23.73 Cr +0.47%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.